Since our results have shown that the PUMA expression, which is up-regulated by p53, is decreased in oxaliplatin resistant CRC cells, and the miR-503-5p expression is increased, we hypothesized that the expression of miR-503-5p be suppressed by p53 in CRC cells. Here, BBC3 is linked to colorectal carcinoma.